Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
Sponsor: Zai Lab (Shanghai) Co., Ltd.
Summary
The purpose of this study is to evaluate the efficacy and safety of ZL-1310 compared to Investigator's Choice Therapy in participants with relapsed Small Cell Lung Cancer.
Official title: A Randomized, Open-Label, Phase 3 Study of ZL-1310, a DLL3 Antibody-Drug Conjugate (ADC), Compared to Investigator's Choice Therapy in Participants With Relapsed Small Cell Lung Cancer
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
480
Start Date
2025-11-30
Completion Date
2028-11-30
Last Updated
2026-10-16
Healthy Volunteers
No
Conditions
Interventions
ZL-1310
ZL-1310 as a single-agent
Investigator's Choice of Therapy
Topotecan or Amrubicin
Locations (165)
University of California San Diego
La Jolla, California, United States
UC Davis Comprehensive Cancer Center
Sacramento, California, United States
University of Colorado
Aurora, Colorado, United States
Yale Cancer Center/Clinical Trials Office
New Haven, Connecticut, United States
Clermont Oncology Center
Clermont, Florida, United States
Mid Florida Hematology and Oncology Center
Orange City, Florida, United States
Cancer Centers of Bevard
Rockledge, Florida, United States
Sarah Cannon Research Institute
Sarasota, Florida, United States
Florida Cancer Specialists - North
St. Petersburg, Florida, United States
Moffitt Cancer Center
Tampa, Florida, United States
Florida Cancer Specialists - East
West Palm Beach, Florida, United States
Illinois Cancer Care
Peoria, Illinois, United States
OSF St. Francis Medical Center
Peoria, Illinois, United States
University of Iowa
Iowa City, Iowa, United States
University of Iowa Mission Health Cancer + Blood
Waukee, Iowa, United States
Norton Cancer Institute
Louisville, Kentucky, United States
American Oncology Partners, PA - The Center for Cancer and Blood Disorders
Bethesda, Maryland, United States
Maryland Oncology Hematology
Silver Spring, Maryland, United States
Henry Ford Health Cancer
Detroit, Michigan, United States
Missouri Cancer Associates
Columbia, Missouri, United States
Mercy South
St Louis, Missouri, United States
Stony Brook Cancer Center
Stony Brook, New York, United States
Montefiore Medical Center
The Bronx, New York, United States
Cleveland Clinic - Akron General Medical Center
Akron, Ohio, United States
University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
Cleveland Clinic - Fairview Hospital Molly Pavilion
Cleveland, Ohio, United States
Cleveland Clinic
Cleveland, Ohio, United States
Cleveland Clinic - Hillcrest Hospital Cancer Center
Mayfield Heights, Ohio, United States
Consultants in Medical Oncology and Hematology
Broomall, Pennsylvania, United States
Alliance Cancer Specialists
Media, Pennsylvania, United States
Allegheny General Hospital
Pittsburgh, Pennsylvania, United States
University of Pittsburgh (UPMC) Hillman Cancer Center
Pittsburgh, Pennsylvania, United States
SCRI OP (Oncology Partners)
Nashville, Tennessee, United States
Texas Oncology - Central South
Austin, Texas, United States
University of Texas Southwestern Medical Center/Clinical Research Department
Dallas, Texas, United States
Texas Oncology - West Texas
Odessa, Texas, United States
Virginia Cancer Specialists
Fairfax, Virginia, United States
Uniklinikum Salzburg, Landeskrankenhaus, Universitatsklinik fur Innere Medizin III der PMU Department of Internal Medicine III
Salzburg, Austria
Medizinische Universitaet Wien - Allgemeines Krankenhaus der Stadt Wien (AKH)
Vienna, Austria
Universitair Ziekenhuis Antwerpen
Edegem, Belgium
Algemeen Ziekenhuis Sint-Lucas
Ghent, Belgium
AZ Maria Middelares - Campus AZ Maria Middelares
Ghent, Belgium
Jessa Ziekenhuis Salvador
Hasselt, Belgium
Universitair Ziekenhuis Brussel
Jette, Belgium
AZ Groeninge
Kortrijk, Belgium
Vivalia St Joseph
Libramont, Belgium
Universite Catholique de Louvain Namur, Centre Hospitalier Universitaire Dinant Godinne
Yvoir, Belgium
Anhui Provincial Hospital
Hefei, Anhui, China
Fujian Cancer Hospital
Fuzhou, Fujian, China
The First Affiliated Hospital of Xiamen University
Xiamen, Fujian, China
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, China
Guangxi Medical University Affiliated Tumor Hospital
Naning, Guangxi, China
Harbin Medical University Cancer Hospital
Heilongjiang, Harbin, China
Fourth Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
Hubei Cancer Hospital
Wuhan, Hubei, China
Hunan Cancer Hospital
Changsha, Hunan, China
Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School
Nanjing, Jiangsu, China
Jiangxi Cancer Hospital
Nanchang, Jiangxi, China
Jilin Cancer Hospital
Changchun, Jilin, China
The First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China
Shandong Cancer Hospital
Jinan, Shandong, China
Linyi Cancer Hospital
Linyi, Shandong, China
Shanghai Pulmonary Hospital
Shanghai, Shanghai Municipality, China
Sichuan Cancer Hospital
Chengdu, Sichuan, China
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China
Taizhou Hospital of Zhejiang Province
Taizhou, Zhejiang, China
Cancer Hospital Chinese Academy of Medical Sciences
Beijing, China
Beijing Cancer Hospital
Beijing, China
Henan cancer Hospital
Zhengzhou, China
Nemocnice Horovice
Hořovice, Czechia
Nemocnice AGEL Ostrava-Vitkovice a. s.
Vítkovice, Czechia
Institut Sainte Catherine
Avignon, France
Hospices Civils de Lyon - Hopital Louis Pradel
Bron, France
Centre Hospitalier Intercommunal de Creteil (CHIC) - Centre de ressources et de competences pour la mucoviscidose (C.R.C.M.)
Créteil, France
Centre Hospitalier - Le Mans
Le Mans, France
Centre Hospitalier Universitaire (CHU) De Limoges Hopital Dupuytren
Limoges, France
Centre Leon-Berard (CLB) - Centre de Recherche en Cancerologie Lyon-Est
Lyon, France
Centre de Recherche Clinique Hôpital de la Croix-Rousse
Lyon, France
Centre Hospitalier Regional Universitaire (CHRU) Montpellier Arnaud de Villeneuve
Montpellier, France
Centre Hospitalier Lyon-Sud, CHLS
Pierre-Bénite, France
Centre Hospitalier de Cornouaille - Hopital Laennec
Quimper, France
Hopital Nord Guillaume-et-Rene-Laennec CHU de Nantes
Saint-Herblain, France
Hopital Foch
Suresnes, France
Centre Hospitalier Intercommunal Toulon La Seyne Sur Mer (C.H.I.T.S) - Hospital Font-Pre
Toulon, France
Clinique Teissier
Valenciennes, France
Klinikum der Johann Wolfgang Goethe-Universität
Frankfurt am Main, Hesse, Germany
Evangelische Lungenklinik Berlin
Berlin, Germany
Krankenhaus Koeln-Merheim
Cologne, Germany
University Hospital Carl Gustav Carus
Dresden, Germany
Krankenhaus Martha-Maria Halle-Doelau gGmbH
Halle, Germany
Studiengesellschaft Haemato-Onkologie Hamburg, Prof. Laack und Partner
Hamburg, Germany
Sotiria General Hospital of Athens
Athens, Greece
University General Hospital of Patras
Rio, Greece
NOSILEFTIKI A.E. - Saint Luke's Clinic
Thessaloniki, Greece
European Interbalkan Medical Center
Thessaloniki, Greece
Iatriko Diavalkaniko Thessalonikis
Thessaloniki, Greece
Azienda Ospedaliero Universitaria Ospedali Riuniti Umberto I
Ancona, Italy
FPO IRCCS Candiolo
Candiolo, Italy
IRCCS Istituto Romagnolo per lo studio dei Tumori "Dino Amadori"(IRST)
Meldola, Italy